Coiled Therapeutics (LSE:COIL) Short Interest


What is Coiled Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:COIL vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Coiled Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coiled Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coiled Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Coiled Therapeutics's Short Interest falls into.


Coiled Therapeutics Business Description

Other Exchanges COTXF:USA0AG0:Germany
Address 85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.